Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 31INDUSTRY 5NIH 2NETWORK 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Sleep Wake Disorders 1Fatty Liver 1Fatigue 1Endometrial Adenocarcinoma 1Depression 1Colorectal Neoplasms 1Breast Neoplasms, Male 1

Interventions

Cyclophosphamide 39Docetaxel 30Tamoxifen 29Paclitaxel 27Doxorubicin 26Trastuzumab 20Radiotherapy 18Epirubicin 16Letrozole 13exemestane 11Fluorouracil 11Anastrozole 11Capecitabine 10Bevacizumab 10Immunohistochemistry 9Filgrastim 9Fulvestrant 8Methotrexate 7Gene Expression Profiling 7palbociclib 6Zoledronic Acid 6Microarray Analysis 6Lapatinib 6Goserelin 6Chemotherapy, Adjuvant 6Amplified Fragment Length Polymorphism Analysis 6Vinorelbine 5Triptorelin Pamoate 5Carboplatin 5Absorptiometry, Photon 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Breast Neoplasms × Metformin × Clear all
NCT01101438 2023-09-13

A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer

Canadian Cancer Trials Group

Phase 3 Completed
3,649 enrolled 17 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT01286233 2015-09-09

Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32

NSABP Foundation Inc

Unknown
394 enrolled
Breast

Breast Neoplasms, Depression, Fatigue, Sleep Wake Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡